Eli Lilly (LLY)
(Delayed Data from NYSE)
$762.33 USD
+22.26 (3.01%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $761.75 -0.58 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LLY 762.33 +22.26(3.01%)
Will LLY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LLY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LLY
Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q2 Earnings
Stock Market News for Aug 1, 2025
LLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
NVO Stock Crashes 22% After 2025 View Cut: More Downside Ahead?
Eli Lilly (LLY) Declines More Than Market: Some Information for Investors
Other News for LLY
Walt Disney, McDonald's, Palantir Set To Report Earnings
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Eli Lilly (LLY) Stock Rises Amid Coverage Expansion for Weight Loss Drugs
Eli Lilly: The Best Growth Prospects Come At A Price
Eli Lilly (LLY) to Benefit from Proposed Coverage of Weight Loss Drugs by Medicare and Medicaid